CNBX News and Press, Cannabics Pharmaceuticals Inc From 09/30/21

Cannabics Announces New Corporate Logo, New Website and New Company Presentation PR Newswire TEL AVIV , Israel and BETHESDA, Md., Sept. 30, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of can...

Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participate at the ICDP Summit in Boston PR Newswire TEL AVIV, Israel and BETHESDA, Md. , Sept. 22, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), ...

Cannabics Pharmaceuticals hires Healthcare Investment Banker Dr. David Sans in New York to expand CNBX in Mental Health Diseases PR Newswire TEL AVIV, Israel and BETHESDA, Maryland , Sept. 21, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc ....

Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine PR Newswire TEL AVIV , Israel and BETHESDA, Md., Sept. 13, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in th...

Hemato-Oncology Expert, Dr. Sigal Tavor (MD) Joins Cannabics Pharmaceuticals' Board of Advisors PR Newswire TEL AVIV , Israel and BETHESDA, Md., Aug. 23, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the deve...

World-Renowned Melanoma Expert Joins Cannabics Pharmaceuticals' Board of Advisors PR Newswire TEL AVIV , Israel and BETHESDA, Maryland, Aug. 4, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the developmen...

Cannabics Pharmaceuticals (CNBX) announces the appointment of Inbar Maymon-Pomeranchik to the company's board as an independent director.Maymon-Pomeranchik is a trained molecular and genetic researcher, and brings nearly 20 years of executive level experience in biotech sciences to the role. ...

Cannabics Pharmaceuticals Announces Appointment of New Independent Board Member PR Newswire TEL AVIV , Israel and BETHESDA, Md., July 7, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer...

Cannabics Pharmaceuticals' Drug Candidate Exhibits 30% Tumor Volume Reduction in Mice PR Newswire TEL AVIV , Israel and BETHESDA, Md., June 28, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of...

Cannabics Pharmaceuticals to launch Drug Development Programs for Prostate Cancer and Neurodegenerative & Mental Health Diseases Cannabics Pharmaceuticals to launch Drug Development Programs for Prostate Cancer and Neurodegenerative & Mental Health Diseases PR Newswi...